Author

Lara Arias-García

SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL
SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL

Lara Arias-García  et al.

LONG-TERM TRENDS IN TARGETED THERAPIES USAGE IN INFLAMMATORY BOWEL DISEASE: TRENDY STUDY OF ENEIDA
LONG-TERM TRENDS IN TARGETED THERAPIES USAGE IN INFLAMMATORY BOWEL DISEASE: TRENDY STUDY OF ENEIDA

Lara Arias-García  et al.

LIVE VACCINES IN CHILDREN EXPOSED TO BIOLOGICAL AGENTS FOR IBD IN UTERO AND/OR DURING BREASTFEEDING: ARE THEY SAFE? RESULTS FROM THE DUMBO REGISTRY OF GETECCU
LIVE VACCINES IN CHILDREN EXPOSED TO BIOLOGICAL AGENTS FOR IBD IN UTERO AND/OR DURING BREASTFEEDING: ARE THEY SAFE? RESULTS FROM THE DUMBO REGISTRY OF GETECCU

Lara Arias-García  et al.

Item 1 - 3 / 3
1